← Eichor
Study identifier: NCT06490276 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Biofeedback Gait Training on Gait Quality in Stroke

Condition: Stroke  ·  Sponsor: National Yang Ming Chiao Tung University

PhaseNA
Planned participants40
Who can joinAll sexes, 20 Years to 80 Years
Healthy volunteersNo

About this study

Post-stroke gait dysfunction is characterized by reduced gait velocity and stride length, along with gait asymmetry and instability. Gait asymmetry and instability are considered as indicators for gait quality, which affect independence and quality of life in individual with stroke. Previous studies have suggested that gait biofeedback is a promising strategy for enhancing the efficacy of post-stroke gait training. However, there is insufficient evidence on the effects of kinematic biofeedback gait training on gait asymmetry and instability in individuals with stroke. Therefore, the purpose of this study is to investigate the effects of real-time kinematic gait biofeedback training on gait quality in individuals with stroke.

This description comes directly from the study's public registry record.

Talk to the study team

Yea-Ru Yang, PhD  ·  +886228267279  ·  yryang@nycu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Physical Therapy and Assistive Technology, National Yang Ming Chiao Tung UniversityTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06490276